Sep 24, 2021
The highly anticipated trial of ex-Theranos CEO Elizabeth Holmes is
underway in San Jose, California. The Stanford dropout who was once
a Silicon Valley darling faces felony charges that she duped elite
financial backers, customers and patients. Her startup, Theranos,
promised to revolutionize the medical world by diagnosing diseases
with just a few drops of blood — but the technology didn’t live up
to expectations and may never have worked at all. What can we
expect from the Theranos Trial?
My guest today is Attorney Tom Lallas. A trial lawyer for more than 42 years, Tom has represented and tried cases for institutional clients, entrepreneurs, real estate investors, commercial lenders, and tech companies and is probably best known for his win in the trial over copyright issues in the Stan Lee v. Marvel case. He frequently appears in the media to comment on and explain legal issues.
Other stories covered include:
COVID-19 and the U.S. courts: challenges to vaccine
requirements
https://www.reuters.com/legal/government/covid-19-us-courts-challenges-vaccine-requirements-2021-09-22/
Gottlieb says vaccines could be approved for kids 5-11 by end of
October
https://www.cbsnews.com/news/covid-19-vaccines-children-october-gottlieb-face-the-nation/
It may take 'many, many' more vaccine mandates to end the
Covid-19 pandemic, Fauci says
https://www.cnn.com/2021/09/13/health/us-coronavirus-monday/index.html
About Dr. Dean Fanelli
Dean Fanelli, Ph.D. is a patent, regulatory, and transactional
attorney in the Washington, DC office of Cooley LLP
(www.cooley.com) focusing on issues related to the development,
protection, and commercialization of biotech and pharmaceutical
products. In addition to Dr. Fanelli's expertise relating to legal
issues involved in pharma and biotech development, Dr. Fanelli also
understands the business needs of his clients as he has co-founded
three biotechnology companies: PhosImmune, Inc. an immuno-oncology
company, C-Reveal Therapeutics, LLC, an immuno-oncology drug
development company focused on exposing tumors to immune responses
and therapies, and most recently AexeRNA Therapeutics, LLC, an mRNA
company developing advanced Lipid Nanoparticle delivery systems
that reduce the side effects present in currently authorized mRNA
COVID-19 vaccines. He is a regular on TV & Radio commenting on
Covid-19 & Vaccines & also hosts his own podcast “Politics & Life
Sciences Radio.”